Cargando…

Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images

OBJECTIVE: To explore multi-aspect radiologic assessment of immunotherapy response in intracranial malignancies based on a semi-automatic segmentation technique, and to explore volumetric thresholds with good performance according to RECIST 1.1 thresholds. METHODS: Patients diagnosed with intracrani...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jia, Liu, Chang, Li, Yan, Ma, Yiqi, Xie, Ruoxi, Li, Zheng, Wan, Hengjiang, Lui, Su, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794597/
https://www.ncbi.nlm.nih.gov/pubmed/36591295
http://dx.doi.org/10.3389/fimmu.2022.1029656
_version_ 1784860072922316800
author Tan, Jia
Liu, Chang
Li, Yan
Ma, Yiqi
Xie, Ruoxi
Li, Zheng
Wan, Hengjiang
Lui, Su
Wu, Min
author_facet Tan, Jia
Liu, Chang
Li, Yan
Ma, Yiqi
Xie, Ruoxi
Li, Zheng
Wan, Hengjiang
Lui, Su
Wu, Min
author_sort Tan, Jia
collection PubMed
description OBJECTIVE: To explore multi-aspect radiologic assessment of immunotherapy response in intracranial malignancies based on a semi-automatic segmentation technique, and to explore volumetric thresholds with good performance according to RECIST 1.1 thresholds. METHODS: Patients diagnosed with intracranial malignancies and treated with immunotherapy were included retrospectively. In all MR images, target lesions were measured using a semi-automatic segmentation technique that could intelligently generate visual diagrams including RECIST 1.1, total volume, and max. 3D diameter. The changes in parameters were calculated for each patient after immunotherapy. The ROC curve was used to analyze the sensitivity and specificity of the size change of the legion. This was useful to find new volumetric thresholds with better efficiency in response assessment. The changes in total volume were assessed by conventional volumetric thresholds, while RECIST 1.1 thresholds were for the max. 3D diameter. A chi-square test was used to compare the concordance and diagnostic correlation between the response assessment results of the three criteria. RESULTS: A total of 20 cases (average age, 58 years; range, 23 to 84 years) and 58 follow-up MR examinations after immunotherapy were included in the analysis. The P-value of the chi-square test between RECIST 1.1 and total volume is 0 (P <0.05), same as that in RECIST 1.1 and max. 3D diameter. The kappa value of the former two was 0.775, and the kappa value for the latter two was 0.742. The above results indicate a significant correlation and good concordance for all three criteria. In addition, we also found that the volumetric assessment had the best sensitivity and specificity for the immunotherapy response in intracranial malignancies, with a PR threshold of −64.9% and a PD threshold of 21.4%. CONCLUSIONS: Radiologic assessment of immunotherapy response in intracranial malignancy can be performed by multiple criteria based on semi-automatic segmentation technique on MR images, such as total volume, max. 3D diameter and RECIST 1.1. In addition, new volumetric thresholds with good sensitivity and specificity were found by volumetric assessment.
format Online
Article
Text
id pubmed-9794597
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97945972022-12-29 Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images Tan, Jia Liu, Chang Li, Yan Ma, Yiqi Xie, Ruoxi Li, Zheng Wan, Hengjiang Lui, Su Wu, Min Front Immunol Immunology OBJECTIVE: To explore multi-aspect radiologic assessment of immunotherapy response in intracranial malignancies based on a semi-automatic segmentation technique, and to explore volumetric thresholds with good performance according to RECIST 1.1 thresholds. METHODS: Patients diagnosed with intracranial malignancies and treated with immunotherapy were included retrospectively. In all MR images, target lesions were measured using a semi-automatic segmentation technique that could intelligently generate visual diagrams including RECIST 1.1, total volume, and max. 3D diameter. The changes in parameters were calculated for each patient after immunotherapy. The ROC curve was used to analyze the sensitivity and specificity of the size change of the legion. This was useful to find new volumetric thresholds with better efficiency in response assessment. The changes in total volume were assessed by conventional volumetric thresholds, while RECIST 1.1 thresholds were for the max. 3D diameter. A chi-square test was used to compare the concordance and diagnostic correlation between the response assessment results of the three criteria. RESULTS: A total of 20 cases (average age, 58 years; range, 23 to 84 years) and 58 follow-up MR examinations after immunotherapy were included in the analysis. The P-value of the chi-square test between RECIST 1.1 and total volume is 0 (P <0.05), same as that in RECIST 1.1 and max. 3D diameter. The kappa value of the former two was 0.775, and the kappa value for the latter two was 0.742. The above results indicate a significant correlation and good concordance for all three criteria. In addition, we also found that the volumetric assessment had the best sensitivity and specificity for the immunotherapy response in intracranial malignancies, with a PR threshold of −64.9% and a PD threshold of 21.4%. CONCLUSIONS: Radiologic assessment of immunotherapy response in intracranial malignancy can be performed by multiple criteria based on semi-automatic segmentation technique on MR images, such as total volume, max. 3D diameter and RECIST 1.1. In addition, new volumetric thresholds with good sensitivity and specificity were found by volumetric assessment. Frontiers Media S.A. 2022-12-14 /pmc/articles/PMC9794597/ /pubmed/36591295 http://dx.doi.org/10.3389/fimmu.2022.1029656 Text en Copyright © 2022 Tan, Liu, Li, Ma, Xie, Li, Wan, Lui and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Tan, Jia
Liu, Chang
Li, Yan
Ma, Yiqi
Xie, Ruoxi
Li, Zheng
Wan, Hengjiang
Lui, Su
Wu, Min
Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title_full Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title_fullStr Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title_full_unstemmed Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title_short Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
title_sort assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794597/
https://www.ncbi.nlm.nih.gov/pubmed/36591295
http://dx.doi.org/10.3389/fimmu.2022.1029656
work_keys_str_mv AT tanjia assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT liuchang assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT liyan assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT mayiqi assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT xieruoxi assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT lizheng assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT wanhengjiang assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT luisu assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages
AT wumin assessmentofimmunotherapyresponseinintracranialmalignancyusingsemiautomaticsegmentationonmagneticresonanceimages